Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

Environmental stresses converge on the mitochondria that can trigger or inhibit cell death. Excitable, postmitotic cells, in response to sublethal noxious stress, engage mechanisms that afford protection from subsequent insults. We show that reoxygenation after prolonged hypoxia reduces the reactive oxygen species (ROS) threshold for the mitochondrial permeability transition (MPT) in cardiomyocytes and that cell survival is steeply negatively correlated with the fraction of depolarized mitochondria. Cell protection that exhibits a memory (preconditioning) results from triggered mitochondrial swelling that causes enhanced substrate oxidation and ROS production, leading to redox activation of PKC, which inhibits glycogen synthase kinase-3beta (GSK-3beta). Alternatively, receptor tyrosine kinase or certain G protein-coupled receptor activation elicits cell protection (without mitochondrial swelling or durable memory) by inhibiting GSK-3beta, via protein kinase B/Akt and mTOR/p70(s6k) pathways, PKC pathways, or protein kinase A pathways. The convergence of these pathways via inhibition of GSK-3beta on the end effector, the permeability transition pore complex, to limit MPT induction is the general mechanism of cardiomyocyte protection.

[1]  R. Jope,et al.  Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation , 2003, Journal of neurochemistry.

[2]  Brian O'Rourke,et al.  Synchronized Whole Cell Oscillations in Mitochondrial Metabolism Triggered by a Local Release of Reactive Oxygen Species in Cardiac Myocytes* , 2003, Journal of Biological Chemistry.

[3]  C. Brenner,et al.  The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. , 2003, Current medicinal chemistry.

[4]  S. Javadov,et al.  Ischaemic Preconditioning Inhibits Opening of Mitochondrial Permeability Transition Pores in the Reperfused Rat Heart , 2003, The Journal of physiology.

[5]  Steven P Jones,et al.  Differential Actions of Cardioprotective Agents on the Mitochondrial Death Pathway , 2003, Circulation research.

[6]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[7]  E. Marbán,et al.  Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes. , 2002, Journal of the American College of Cardiology.

[8]  G. Lopaschuk,et al.  Leptin Activates Cardiac Fatty Acid Oxidation Independent of Changes in the AMP-activated Protein Kinase-Acetyl-CoA Carboxylase-Malonyl-CoA Axis* , 2002, The Journal of Biological Chemistry.

[9]  S. Krajewski,et al.  Calpain and Mitochondria in Ischemia/Reperfusion Injury* , 2002, The Journal of Biological Chemistry.

[10]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[11]  P. dos Santos,et al.  Mechanisms by which opening the mitochondrial ATP- sensitive K(+) channel protects the ischemic heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[12]  D. Yellon,et al.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.

[13]  W. Stanley Partial fatty acid oxidation inhibitors for stable angina , 2002, Expert opinion on investigational drugs.

[14]  E. Murphy,et al.  Phosphorylation of Glycogen Synthase Kinase-3&bgr; During Preconditioning Through a Phosphatidylinositol-3-Kinase–Dependent Pathway Is Cardioprotective , 2002, Circulation research.

[15]  A. Avogaro,et al.  Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. , 2002, Diabetes.

[16]  J. Weiss,et al.  Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[18]  E. Olson,et al.  Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Olson,et al.  Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Coats MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[21]  R. Kloner,et al.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. , 2001, Circulation.

[22]  J. Balligand,et al.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.

[23]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.

[24]  G. Dorn,et al.  Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Sollott,et al.  Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes , 2001, Circulation research.

[26]  Laurence H. Pearl,et al.  Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.

[27]  Jianxin Chen,et al.  Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. , 2001, American journal of physiology. Cell physiology.

[28]  Y. Ho,et al.  Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[29]  A E Vercesi,et al.  Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.

[30]  A. Reith,et al.  Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death , 2001, Journal of neurochemistry.

[31]  M. Yaffe,et al.  A motif-based profile scanning approach for genome-wide prediction of signaling pathways , 2001, Nature Biotechnology.

[32]  G. Dorn,et al.  Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Kloner,et al.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. , 2001, Circulation.

[34]  E. Lakatta,et al.  The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase , 2000 .

[35]  S. Korsmeyer,et al.  The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2 , 2000, Nature Cell Biology.

[36]  Steven J. Sollott,et al.  Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.

[37]  J. Downey,et al.  Opening of Mitochondrial KATP Channels Triggers the Preconditioned State by Generating Free Radicals , 2000, Circulation research.

[38]  A. Hagège,et al.  Cardiac functional improvement by a human Bcl‐2 transgene in a mouse model of ischemia/reperfusion injury , 2000, The journal of gene medicine.

[39]  G. Gross The role of mitochondrial KATP channels in cardioprotection , 2000, Basic Research in Cardiology.

[40]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[41]  Y. Tsujimoto,et al.  BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Lakatta,et al.  The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. , 2000, Circulation research.

[43]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.

[44]  Y. Tsujimoto,et al.  Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death , 1999, Oncogene.

[45]  I. Angin Sulfonylurea Drugs Increase Early Mortality in Patients with Diabetes Mellitus after Direct Angioplasty for Acute Myocardial Infarction , 1999 .

[46]  EduardoMarbán,et al.  Modulation of Mitochondrial ATP-Dependent K+ Channels by Protein Kinase C , 1998 .

[47]  E. Marbán,et al.  Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. , 1998, Circulation research.

[48]  Douglas C. Wallace,et al.  Radicals r'aging , 1998, Nature Genetics.

[49]  E. Braunwald,et al.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.

[50]  B. Mignotte,et al.  Mitochondria and apoptosis. , 1998, European journal of biochemistry.

[51]  M. Smith,et al.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.

[52]  J. Downey,et al.  Signal transduction of ischemic preconditioning. , 1997, Cardiovascular research.

[53]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[54]  P. Abete,et al.  Preconditioning does not prevent postischemic dysfunction in aging heart. , 1996, Journal of the American College of Cardiology.

[55]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[56]  C. Croce,et al.  Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Mochly‐Rosen Localization of protein kinases by anchoring proteins: a theme in signal transduction. , 1995, Science.

[58]  J. Downey,et al.  Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. , 1994, Cardiovascular research.

[59]  J. Downey,et al.  Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. , 1993, Cardiovascular research.

[60]  J. Downey,et al.  Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. , 1993, Cardiovascular research.

[61]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.

[62]  T. Higuti,et al.  ATP-sensitive K+ channel in the mitochondrial inner membrane , 1991, Nature.

[63]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[64]  M. Crompton,et al.  A heart mitochondrial Ca2(+)-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. , 1990, The Biochemical journal.

[65]  A. Halestrap The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. , 1989, Biochimica et biophysica acta.

[66]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[67]  E. Lakatta,et al.  Single adult rabbit and rat cardiac myocytes retain the Ca2+- and species-dependent systolic and diastolic contractile properties of intact muscle , 1986, The Journal of general physiology.

[68]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. , 1979, Archives of biochemistry and biophysics.

[69]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. , 1979, Archives of biochemistry and biophysics.

[70]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[71]  C. Mannella,et al.  Small-angle X-ray scattering from mitochondria. , 1977, Biochimica et biophysica acta.